CORE
πΊπ¦Β
Β make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Cystic Fibrosis
Authors
DA Christie
EM Tansey
Publication date
15 July 2004
Publisher
Wellcome Trust
Abstract
First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2004. Β©The Trustee of the Wellcome Trust, London, 2004. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 11 June 2002. Introduction by Professor John Dodge.Annotated and edited transcript of a Witness Seminar held on 11 June 2002. Introduction by Professor John Dodge.Annotated and edited transcript of a Witness Seminar held on 11 June 2002. Introduction by Professor John Dodge.Annotated and edited transcript of a Witness Seminar held on 11 June 2002. Introduction by Professor John Dodge.Annotated and edited transcript of a Witness Seminar held on 11 June 2002. Introduction by Professor John Dodge.Annotated and edited transcript of a Witness Seminar held on 11 June 2002. Introduction by Professor John Dodge.In the 1930s, when cystic fibrosis (CF) was first clearly recognised, it was a disorder that inevitably led to death in early childhood from respiratory failure and malnutrition. Since that time, antibiotic treatment and improving nutrition have brought increasing hope to sufferers from the disorder, so that increasing numbers of children have lived on into adult life. Chaired by Professor John Walker-Smith, and attended by a group of leading experts in field at the time, this transcript discusses the history and development of treatment as a result of the establishment of multidisciplinary teams working at special CF centres. Participants also discussed the role of the Cystic Fibrosis Trust and the identification in 1989 of the defective gene, which made antenatal diagnosis possible and suggests that gene therapy might become feasible in the future. Christie D A, Tansey E M. (eds) (2004) Cystic fibrosis, Wellcome Witnesses to Twentieth Century Medicine, vol. 20. London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at University College London is funded by the Wellcome Trust,which is a registered charity, no. 210183
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Supporting member
Queen Mary Research Online
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:qmro.qmul.ac.uk:123456789/...
Last time updated on 05/04/2016